Related Experiment Video
Updated: Jun 15, 2026
06:38
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
[Management of hepatocellular carcinoma]
1Service de gastro-entérologie et d'hépatologie, CHUV, Lausanne. lsabelle.Pache@chuv.ch
Revue Medicale Suisse
|March 11, 2010
Summary
Hepatocellular carcinoma (HCC), a common cancer, often arises in patients with liver cirrhosis. Early detection through surveillance and a multidisciplinary approach are key for effective treatment of this growing global health concern.
Area of Science:
- Oncology
- Hepatology
- Gastroenterology
Context:
- Hepatocellular carcinoma (HCC) is a prevalent malignancy with increasing incidence globally.
- Most HCC cases develop in patients with underlying liver cirrhosis.
- Hepatitis B virus infection is a significant risk factor for HCC development.
Purpose:
- To highlight the importance of surveillance programs for at-risk populations.
- To outline diagnostic pathways for focal liver lesions.
- To emphasize the need for tailored treatment strategies in HCC management.
Summary:
- Surveillance programs are crucial for patients with liver cirrhosis and hepatitis B virus infection.
- Ultrasound detection of liver lesions requires further investigation for diagnosis and staging.
- Treatment decisions for HCC depend on tumor stage, liver function, portal hypertension, and patient's overall health.
Impact:
- Promotes early detection and diagnosis of hepatocellular carcinoma.
- Underscores the necessity of a multidisciplinary team for optimal patient care.
- Facilitates personalized treatment planning for improved patient outcomes in HCC.
